Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38


18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma.

Kasenda B, Haug V, Schorb E, Fritsch K, Finke J, Mix M, Hader C, Weber WA, Illerhaus G, Meyer PT.

J Nucl Med. 2013 Feb;54(2):184-91. doi: 10.2967/jnumed.112.108654. Epub 2012 Dec 18.


Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.

Tripathi M, Sharma R, Varshney R, Jaimini A, Jain J, Souza MM, Bal J, Pandey S, Kumar N, Mishra AK, Mondal A.

Clin Nucl Med. 2012 Feb;37(2):158-63. doi: 10.1097/RLU.0b013e318238f51a.


An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.

Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58. doi: 10.1016/j.ijrobp.2010.07.002. Epub 2011 May 11.


Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.

Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ.

Lancet Neurol. 2010 Sep;9(9):906-20. doi: 10.1016/S1474-4422(10)70181-2. Epub 2010 Aug 10. Review.


Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

Piroth MD, Pinkawa M, Holy R, Klotz J, Nussen S, Stoffels G, Coenen HH, Kaiser HJ, Langen KJ, Eble MJ.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):176-84. doi: 10.1016/j.ijrobp.2010.01.055. Epub 2010 Jun 18.


Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM.

J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15.


Pseudoprogression and pseudoresponse in the treatment of gliomas.

Brandsma D, van den Bent MJ.

Curr Opin Neurol. 2009 Dec;22(6):633-8. doi: 10.1097/WCO.0b013e328332363e. Review.


Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Taal W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Smitt PA, van Es CA, van den Bent MJ.

Cancer. 2008 Jul 15;113(2):405-10. doi: 10.1002/cncr.23562.


Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.

Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K.

J Nucl Med. 2008 May;49(5):694-9. doi: 10.2967/jnumed.107.048082. Epub 2008 Apr 15.


Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.

Ullrich R, Backes H, Li H, Kracht L, Miletic H, Kesper K, Neumaier B, Heiss WD, Wienhard K, Jacobs AH.

Clin Cancer Res. 2008 Apr 1;14(7):2049-55. doi: 10.1158/1078-0432.CCR-07-1553.


Simultaneous PET-MRI: a new approach for functional and morphological imaging.

Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Röcken M, Nutt RE, Machulla HJ, Uludag K, Cherry SR, Claussen CD, Pichler BJ.

Nat Med. 2008 Apr;14(4):459-65. doi: 10.1038/nm1700. Epub 2008 Mar 23.


FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Pöpperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K.

Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1933-42. Epub 2007 Sep 1.


Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?

Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1135-44. Epub 2007 Jan 8.


EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.

Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, Varrone A, Tatsch K; European Association of Nuclear Medicine (EANM).

Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1374-80. No abstract available.


Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, O'Keefe GJ, Sachinidis JI, Berlangieri SU, Fabinyi G, Scott AM.

J Nucl Med. 2006 Mar;47(3):410-8.


Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.

Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U, Debus J.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):222-7. Epub 2006 Feb 20.


Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.

Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):892-7.


Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.

Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, Senda M, Ishii K, Hirakawa K, Ohno K.

J Neurosurg. 2005 Sep;103(3):498-507.


Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.

Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.


Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH.

AJNR Am J Neuroradiol. 2005 Sep;26(8):1967-72.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk